3/24
07:44 pm
mnkd
How The MannKind (MNKD) Story Is Shifting As Tyvaso Risks Meet Afrezza And Furoscix Potential [Yahoo! Finance]
Low
Report
How The MannKind (MNKD) Story Is Shifting As Tyvaso Risks Meet Afrezza And Furoscix Potential [Yahoo! Finance]
3/18
07:38 am
mnkd
MannKind: Strategic Uncertainty Follows United Therapeutics' Pivot (Rating Downgrade) [Seeking Alpha]
Medium
Report
MannKind: Strategic Uncertainty Follows United Therapeutics' Pivot (Rating Downgrade) [Seeking Alpha]
3/13
06:18 am
mnkd
MannKind (MNKD) was downgraded by Zacks Research from "hold" to "strong sell".
Low
Report
MannKind (MNKD) was downgraded by Zacks Research from "hold" to "strong sell".
3/11
03:36 pm
mnkd
MannKind Corporation (MNKD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
MannKind Corporation (MNKD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/11
10:01 am
mnkd
MannKind CEO purchases 100,000 shares; stock climbs [Seeking Alpha]
Low
Report
MannKind CEO purchases 100,000 shares; stock climbs [Seeking Alpha]
3/9
09:44 am
mnkd
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026 [Yahoo! Finance]
Medium
Report
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026 [Yahoo! Finance]
3/9
09:05 am
mnkd
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
Low
Report
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
3/8
08:03 pm
mnkd
How The MannKind (MNKD) Investment Story Is Shifting With New Risks And 2026 Catalysts [Yahoo! Finance]
Low
Report
How The MannKind (MNKD) Investment Story Is Shifting With New Risks And 2026 Catalysts [Yahoo! Finance]
3/5
08:10 pm
mnkd
MannKind Corp (MNKD) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... [Yahoo! Finance]
Medium
Report
MannKind Corp (MNKD) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... [Yahoo! Finance]
3/5
04:57 pm
mnkd
MannKind Announces Settlement of Convertible Senior Notes [Yahoo! Finance]
Medium
Report
MannKind Announces Settlement of Convertible Senior Notes [Yahoo! Finance]
3/5
04:30 pm
mnkd
MannKind Announces Settlement of Convertible Senior Notes
Medium
Report
MannKind Announces Settlement of Convertible Senior Notes
3/5
08:52 am
mnkd
MannKind (MNKD) had its price target lowered by Wedbush from $10.00 to $8.00. They now have an "outperform" rating on the stock.
Medium
Report
MannKind (MNKD) had its price target lowered by Wedbush from $10.00 to $8.00. They now have an "outperform" rating on the stock.
3/4
09:35 am
mnkd
MannKind to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
MannKind to Participate in Upcoming Investor Conferences [Yahoo! Finance]
3/4
09:00 am
mnkd
MannKind to Participate in Upcoming Investor Conferences
Low
Report
MannKind to Participate in Upcoming Investor Conferences
3/4
06:06 am
mnkd
MannKind Corporation (MNKD) Outlines Expansion Plans and Revenue Targets [Yahoo! Finance]
Neutral
Report
MannKind Corporation (MNKD) Outlines Expansion Plans and Revenue Targets [Yahoo! Finance]
3/3
06:14 pm
mnkd
MannKind (MNKD) was downgraded by
Weiss Ratings from "hold (c)" to "sell (d+)".
Low
Report
MannKind (MNKD) was downgraded by
Weiss Ratings from "hold (c)" to "sell (d+)".
2/28
09:25 pm
mnkd
MannKind at Oppenheimer: 2025 Revenue Jumps 46%, Eyes $450M+ in 2026 on Afrezza and FUROSCIX [Yahoo! Finance]
Medium
Report
MannKind at Oppenheimer: 2025 Revenue Jumps 46%, Eyes $450M+ in 2026 on Afrezza and FUROSCIX [Yahoo! Finance]
2/28
01:38 pm
mnkd
MannKind Corporation (MNKD): A Bull Case Theory [Yahoo! Finance]
Medium
Report
MannKind Corporation (MNKD): A Bull Case Theory [Yahoo! Finance]
2/27
11:41 am
mnkd
MannKind (MNKD) had its price target lowered by Wells Fargo & Company from $8.00 to $7.00. They now have an "overweight" rating on the stock.
Low
Report
MannKind (MNKD) had its price target lowered by Wells Fargo & Company from $8.00 to $7.00. They now have an "overweight" rating on the stock.
2/27
08:44 am
mnkd
MannKind (MNKD) had its "sector perform" rating reaffirmed by Royal Bank Of Canada. They now have a $3.50 price target on the stock.
Medium
Report
MannKind (MNKD) had its "sector perform" rating reaffirmed by Royal Bank Of Canada. They now have a $3.50 price target on the stock.
2/27
06:33 am
mnkd
Reassessing MannKind (MNKD) After Sharp Recent Share Price Declines [Yahoo! Finance]
Low
Report
Reassessing MannKind (MNKD) After Sharp Recent Share Price Declines [Yahoo! Finance]
2/26
06:45 pm
mnkd
Why MannKind Stock Tumbled on Thursday [Yahoo! Finance]
Low
Report
Why MannKind Stock Tumbled on Thursday [Yahoo! Finance]
2/26
05:06 pm
mnkd
MannKind Corporation (MNKD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
MannKind Corporation (MNKD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/26
05:06 pm
mnkd
MannKind outlines $450M 2026 revenue run rate and key product catalysts amid Afrezza pediatric launch preparations [Seeking Alpha]
Low
Report
MannKind outlines $450M 2026 revenue run rate and key product catalysts amid Afrezza pediatric launch preparations [Seeking Alpha]
2/26
03:37 pm
mnkd
MannKind (MNKD) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
Low
Report
MannKind (MNKD) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]